219 related articles for article (PubMed ID: 22099822)
41. Ionised and total serum magnesium in renal transplant patients.
Mazzaferro S; Barberi S; Scarda A; Pasquali M; Rubino F; D'Erasmo E
J Nephrol; 2002; 15(3):275-80. PubMed ID: 12113599
[TBL] [Abstract][Full Text] [Related]
42. Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.
Lomonte C; Antonelli M; Losurdo N; Marchio G; Giammaria B; Basile C
Nephrol Dial Transplant; 2007 Jul; 22(7):2056-62. PubMed ID: 17449495
[TBL] [Abstract][Full Text] [Related]
43. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA
Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
[TBL] [Abstract][Full Text] [Related]
44. The effects of mineral metabolism markers on renal transplant outcomes.
Marcén R; Jimenez S; Fernández A; Galeano C; Villafruela JJ; Burgos FJ; Quereda C
Transplant Proc; 2012 Nov; 44(9):2567-9. PubMed ID: 23146456
[TBL] [Abstract][Full Text] [Related]
45. Conjunctival and corneal calcification and bone metabolism in hemodialysis patients.
Tokuyama T; Ikeda T; Sato K; Mimura O; Morita A; Tabata T
Am J Kidney Dis; 2002 Feb; 39(2):291-6. PubMed ID: 11840369
[TBL] [Abstract][Full Text] [Related]
46. [Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].
Zhang L; Yao L; Hua Z; Bian WJ; Li WG
Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):562-7. PubMed ID: 22041265
[TBL] [Abstract][Full Text] [Related]
47. [CA-P control in haemodialysis and K/DOQI guidelines].
Rivera F; Sánchez de la Nieta MD; Echarri R; Anaya S; Carreño A; Vozmediano MC; Alcaide MP
Nefrologia; 2006; 26(3):351-7. PubMed ID: 16892824
[TBL] [Abstract][Full Text] [Related]
48. Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism.
Chou FF; Lee CH; Chen JB; Huang SC; Lee CT
Surgery; 2005 Apr; 137(4):426-30. PubMed ID: 15800490
[TBL] [Abstract][Full Text] [Related]
49. Kinetics of serum 1,84 iPTH after high dose of calcitriol in uremic patients.
Seidel A; Herrmann P; Klaus G; Mehls O; Schmidt-Gayk H; Ritz E
Clin Nephrol; 1993 Apr; 39(4):210-3. PubMed ID: 8491051
[TBL] [Abstract][Full Text] [Related]
50. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
[TBL] [Abstract][Full Text] [Related]
51. Primary hyperparathyroidism with normal serum intact parathyroid hormone levels.
Mischis-Troussard C; Goudet P; Verges B; Cougard P; Tavernier C; Maillefert JF
QJM; 2000 Jun; 93(6):365-7. PubMed ID: 10873186
[TBL] [Abstract][Full Text] [Related]
52. Effect of a dietitian-managed bone algorithm on serum phosphorus level in maintenance hemodialysis patients.
Blair D; Byham-Gray L; Sweet SJ; Denmark R; Parrott JS; Lewis E; McCaffrey S; Thomson S
J Ren Nutr; 2013 Mar; 23(2):98-105.e2. PubMed ID: 22800689
[TBL] [Abstract][Full Text] [Related]
53. Bone histology in patients with nephrotic syndrome and normal renal function.
Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S
Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454
[TBL] [Abstract][Full Text] [Related]
54. Intact parathyroid hormone levels in renal insufficiency.
Fajtova VT; Sayegh MH; Hickey N; Aliabadi P; Lazarus JM; LeBoff MS
Calcif Tissue Int; 1995 Nov; 57(5):329-35. PubMed ID: 8564794
[TBL] [Abstract][Full Text] [Related]
55. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
Moore C; Yee J; Malluche H; Rao DS; Monier-Faugere MC; Adams E; Daramola-Ogunwuyi O; Fehmi H; Bhat S; Osman-Malik Y
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1484-1493. PubMed ID: 19713297
[TBL] [Abstract][Full Text] [Related]
56. Effect of Cinacalcet Combined with Calcitriol on the Clinical Outcome and Bone Metabolism in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism.
Yuan F; Chen X; Wang C; Li Z; Liu H
Blood Purif; 2018; 45(1-3):73-78. PubMed ID: 29216631
[TBL] [Abstract][Full Text] [Related]
57. Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry study.
Bonthuis M; Busutti M; van Stralen KJ; Jager KJ; Baiko S; Bakkaloğlu S; Battelino N; Gaydarova M; Gianoglio B; Parvex P; Gomes C; Heaf JG; Podracka L; Kuzmanovska D; Molchanova MS; Pankratenko TE; Papachristou F; Reusz G; Sanahuja MJ; Shroff R; Groothoff JW; Schaefer F; Verrina E
Clin J Am Soc Nephrol; 2015 May; 10(5):767-75. PubMed ID: 25710805
[TBL] [Abstract][Full Text] [Related]
58. Calcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, "sick," and hypocalcemic newborns.
David L; Anast CS
J Clin Invest; 1974 Aug; 54(2):287-96. PubMed ID: 4858778
[TBL] [Abstract][Full Text] [Related]
59. Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients.
Ohya M; Negi S; Sakaguchi T; Koiwa F; Ando R; Komatsu Y; Shinoda T; Inaguma D; Joki N; Yamaka T; Ikeda M; Shigematsu T
J Clin Endocrinol Metab; 2014 Oct; 99(10):3873-8. PubMed ID: 24937533
[TBL] [Abstract][Full Text] [Related]
60. Renal osteodystrophy in pediatric patients on peritoneal dialysis.
Cano FJ; Valenzuela M; Zambrano P; Azocar MA; Wolff E; Delucchi MA; Rodriguez EE
Adv Perit Dial; 2004; 20():237-44. PubMed ID: 15384834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
